ALTOR BIOSCIENCE, LLC
CULVER CITY, CA

Altos BioScience, LLC is a clinical-stage biopharmaceutical company dedicated to developing innovative immunotherapies for cancer and viral infections. Founded in 2002 by Dr. Hing C. Wong as a spin-off from Sunol Molecular Corporation ("Sunol"), the company leverages its proprietary engineered cytokine technology platforms. Backed by leading venture capital investors, including Sanderling Ventures and TVM Capital, Altos BioScience is positioned at the forefront of therapeutic advancements in the biotech industry. Based in Florida with its headquarters located at 9920 Jefferson Blvd, Suite 1, Culver City, CA, USA, the company operates under status as a Foreign Qualification Corporation Limited (FORL) since its incorporation on December 11, 2017. Altos BioScience's operations span across counties including Broward and are registered in Delaware with Filed Number M17000010432. The company maintains an active communication channel through phone numbers (954) 443-8600 and (954) 443-8610. More information about its innovative solutions, corporate governance, and investor resources can be accessed via its official website at altorbioscience.com. As of April 29, 2024, Altos BioScience has submitted the latest annual report for the year 2024, showcasing transparency and accountability in its financial disclosures with Fei Number 30-0999738. Under the leadership of key officers such as CFO David Sachs, Altos BioScience continues to pave the way for groundbreaking treatments leveraging its dual technology platforms.